Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate whether the measure of the optic nerve sheath is a reliable diagnostic marker for giant cell arteritis
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hôpital NOVO
NCT07246577 · Giant Cell Arteritis (GCA)
NCT06887062 · Large Vessel Vasculitis, Giant Cell Arteritis (GCA), and more
NCT06609668 · Giant Cell Arteritis (GCA), Polymyalgia Rheumatica (PMR)
NCT07459335 · Giant Cell Arteritis (GCA), Cardiovascular Diseases
NCT03725202 · Giant Cell Arteritis (GCA)
Rhumatology departement - Centre Hospitalier Aix en Provence
Aix-en-Provence
Rhumatology department - Centre Hospitalier Universitaire de Brest
Brest
Internal Medecine Department- CHU Caen
Caen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions